as reported.28 (link) 4-((tButyldimethylsilyl)oxy)butan-1-ol was obtained from Santa
Cruz Biotechnology and used as received. All other chemicals and solvents
were purchased from Merck or VWR and were used as received as well.
Deoxygenated and anhydrous solvents were obtained from a PureSolv
PS-MD-5 solvent dispenser (Innovative Technology). Column chromatography
was performed on alumina (Al2O3, activated,
basic, Brockmann I, 58 Å pore size, pH 9.5 ± 0.5) . Thin
layer chromatography (TLC) was performed using TLC plates from Machery-Nagel
(Alugram Aloz, Al2O3, with F254 indicator
on aluminum backing, pH 9). Compounds were visualized on TLC plates
by UV detection at 254 nm. 1H, COSY, 13C APT,
HSQC, and HMBC NMR spectra were recorded on a Bruker 400 MHz (100.6
MHz for 13C) NMR spectrometer using the residual solvent
as internal standard. Mass spectra were obtained by high resolution
mass spectrometry (HRMS) using a TOF Synapt G2-Si mass spectrometer
equipped with an electrospray ionization source in positive ion mode
with leu-enkephalin (m/z = 556.2771)
as an internal lock mass. TLC/mass spectrometry (TLC/MS) analysis
was performed on an Advion Plate Express TLC Plate Reader connected
to an Advion expressionL CMS mass spectrometer.